BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37723516)

  • 21. Microdiscectomy Is More Cost-effective Than a 6-Month Nonsurgical Care Regimen for Chronic Radiculopathy.
    Glennie RA; Urquhart JC; Koto P; Rasoulinejad P; Taylor D; Sequeira K; Miller T; Watson J; Rosedale R; Bailey SI; Gurr KR; Siddiqi F; Bailey CS
    Clin Orthop Relat Res; 2022 Mar; 480(3):574-584. PubMed ID: 34597280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France.
    Chouaid C; Bensimon L; Clay E; Millier A; Levy-Bachelot L; Huang M; Levy P
    Lung Cancer; 2019 Jan; 127():44-52. PubMed ID: 30642550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland.
    Bhadhuri A; Insinga R; Guggisberg P; Panje C; Schwenkglenks M
    Swiss Med Wkly; 2019 Dec; 149():w20170. PubMed ID: 31880807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study protocol for VIdeo assisted thoracoscopic lobectomy versus conventional Open LobEcTomy for lung cancer, a UK multicentre randomised controlled trial with an internal pilot (the VIOLET study).
    Lim E; Batchelor T; Shackcloth M; Dunning J; McGonigle N; Brush T; Dabner L; Harris R; Mckeon HE; Paramasivan S; Elliott D; Stokes EA; Wordsworth S; Blazeby J; Rogers CA;
    BMJ Open; 2019 Oct; 9(10):e029507. PubMed ID: 31615795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating Cost-Effectiveness Using Alternative Preference-Based Scores and Within-Trial Methods: Exploring the Dynamics of the Quality-Adjusted Life-Year Using the EQ-5D 5-Level Version and Recovering Quality of Life Utility Index.
    Franklin M; Hunter RM; Enrique A; Palacios J; Richards D
    Value Health; 2022 Jun; 25(6):1018-1029. PubMed ID: 35667775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial).
    Grant AM; Boachie C; Cotton SC; Faria R; Bojke L; Epstein DM; Ramsay CR; Corbacho B; Sculpher M; Krukowski ZH; Heading RC; Campbell MK;
    Health Technol Assess; 2013 Jun; 17(22):1-167. PubMed ID: 23742987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost effectiveness of home ultraviolet B phototherapy for psoriasis: economic evaluation of a randomised controlled trial (PLUTO study).
    Koek MB; Sigurdsson V; van Weelden H; Steegmans PH; Bruijnzeel-Koomen CA; Buskens E
    BMJ; 2010 Apr; 340():c1490. PubMed ID: 20406865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation.
    Murray A; Lourenco T; de Verteuil R; Hernandez R; Fraser C; McKinley A; Krukowski Z; Vale L; Grant A
    Health Technol Assess; 2006 Nov; 10(45):1-141, iii-iv. PubMed ID: 17083853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cooled radiofrequency ablation of the genicular nerves for chronic pain due to osteoarthritis of the knee: a cost-effectiveness analysis compared with intra-articular hyaluronan injections based on trial data.
    Desai MJ; Bentley A; Keck WA
    BMC Musculoskelet Disord; 2022 May; 23(1):491. PubMed ID: 35610642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people: PREDICT.
    McMillan A; Bratton DJ; Faria R; Laskawiec-Szkonter M; Griffin S; Davies RJ; Nunn AJ; Stradling JR; Riha RL; Morrell MJ
    Health Technol Assess; 2015 Jun; 19(40):1-188. PubMed ID: 26063688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-Utility Analysis of Continuation Versus Discontinuation of First-Line Chemotherapy in Patients With Metastatic Squamous-Cell Esophageal Cancer: Economic Evaluation Alongside the E-DIS Trial.
    Marguet S; Adenis A; Delaine-Clisant S; Penel N; Bonastre J
    Value Health; 2021 May; 24(5):676-682. PubMed ID: 33933236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of steroid (methylprednisolone) injections versus anaesthetic alone for the treatment of Morton's neuroma: economic evaluation alongside a randomised controlled trial (MortISE trial).
    Edwards RT; Yeo ST; Russell D; Thomson CE; Beggs I; Gibson JN; McMillan D; Martin DJ; Russell IT
    J Foot Ankle Res; 2015; 8():6. PubMed ID: 25737743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of osimertinib in the UK for advanced EGFR-T790M non-small cell lung cancer.
    Bertranou E; Bodnar C; Dansk V; Greystoke A; Large S; Dyer M
    J Med Econ; 2018 Feb; 21(2):113-121. PubMed ID: 28880737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative physiotherapy is cost-effective for preventing pulmonary complications after major abdominal surgery: a health economic analysis of a multicentre randomised trial.
    Boden I; Robertson IK; Neil A; Reeve J; Palmer AJ; Skinner EH; Browning L; Anderson L; Hill C; Story D; Denehy L
    J Physiother; 2020 Jul; 66(3):180-187. PubMed ID: 32680742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical effectiveness and cost-effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial.
    Brittenden J; Cotton SC; Elders A; Tassie E; Scotland G; Ramsay CR; Norrie J; Burr J; Francis J; Wileman S; Campbell B; Bachoo P; Chetter I; Gough M; Earnshaw J; Lees T; Scott J; Baker SA; MacLennan G; Prior M; Bolsover D; Campbell MK
    Health Technol Assess; 2015 Apr; 19(27):1-342. PubMed ID: 25858333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anal fistula plug versus surgeon's preference for surgery for trans-sphincteric anal fistula: the FIAT RCT.
    Jayne DG; Scholefield J; Tolan D; Gray R; Edlin R; Hulme CT; Sutton AJ; Handley K; Hewitt CA; Kaur M; Magill L
    Health Technol Assess; 2019 May; 23(21):1-76. PubMed ID: 31113531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis of nivolumab plus ipilimumab plus two cycles of platinum-doublet chemotherapy versus platinum-doublet chemotherapy alone for first-line treatment of stage IV or recurrent non-small cell lung cancer in the United States.
    Polyzoi M; Sandhu H; Maervoet J; Yuan Y; Chaudhary MA; Varol N; Lee A; Dale P; Jones C; Lubinga SJ; Penrod JR
    J Med Econ; 2022; 25(1):660-668. PubMed ID: 35658806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.